In vitro and in vivo incorporation of 63Ni[II] into lung and liver subcellular fractions of Balb/C mice.

The binding of nickel to proteins in lung and in liver was investigated by analysis of 63Ni[II] incorporation into the nuclear, mitochondrial, microsomal and soluble fractions. Three different procedures were performed: (i) in vitro incorporation, (ii) a time course study of in vivo incorporation where the animals were sacrificed after 30 min, 1, 2 and 4 h after a single i.p.

63Ni[II]-incorporation into lung and liver cytosol of Balb/C mouse. An in vitro and in vivo study.

The kinetic studies of 63Ni[II]-incorporation in whole tissue show that after 6 days lung has the highest affinity to nickel of all studied organs. The same observation was made when 63Ni[II]-incorporation was carried out by 7 daily injections. In both experiments, kidneys take the second place in the relative distribution of nickel.

Structures of fifteen oligosaccharides isolated from new-born meconium.

New born meconium contains at least a hundred oligosaccharides. In this study the isolation and characterization of the major constituents is described. The structure elucidation of 15 neutral and acidic oligosaccharides was carried out by methylation analysis, mass spectrometry and 360-MHz 1H-NMR spectroscopy.

Structure of seven oligosaccharides excreted in the urine of a patient with Sandhoff's disease (GM2 gangliosidosis-variant O).

The urine of a patient with Sandhoff's disease (GM2 gangliosidosis-variant O) contains 10--12 N-acetylglucosamine-rich oligosaccharides in high amounts. The structures of seven of these have been determined: beta-GlcNAc(1--2)-alpha-Man-(1--3)-beta-man-(1--4)-GlcNAc; beta-GlcNAc-(1--4)-alpha-Man-(1--3)-beta-Man-(1--4)-GlcNAc; beta-GlcNAc-(1--2)-alpha-Man-(1--6)-beta-Man-(1--4)-GlcNAc; beta-GlcNAc-(1--4)-alpha-Man-(1--6)-beta-Man-(1--4)-GlcNAc; beta-GlcNAc-(1--2)-alpha-Man-(1--3)-[beta-GlcNAc-(1--2)-alpha-Man-(1--6)]beta-Man-(1--4)-GlcNAc; beta-GlcNAc-(1--2)-alpha-Man-(1--3)[beta-GlcNAc-(1--2)-alpha-Man-(1--6)][beta-GlcNAc-(1--4)]beta-Man-(1--4)-GlcNAc; beta-GlcNAc-(1--2)-alpha-Man(1)-(1--3)[beta-GlcNAc-(1--2)-alpha-Man(2)-(1--6)]beta-Man-(1--4)-GlcNAc, with additional beta-GlcNAc, with additional beta-GlcNAc-(1--4) on mannose (1) or (2). An unusual oligosaccharide, with a tri-branched beta-mannose, has been characterized as the major component excreted in urine.